The side effect profile mirrors what you'd expect from GLP-1-based drugs: Nausea, particularly when starting or increasing the dose Diarrhoea and, less often, constipation Reduced appetite (which is, of course, partly the point) Tiredness in the first few weeks Occasional vomiting at higher doses In the Phase 2 trials, most side effects were rated mild to moderate and tended to settle as the body adjusted
But a smaller appetite doesnt mean your body needs less nutrition
Some patients describe it as a taste of metal in mouth and nausea, especially in the early stages or during dose increases
On one hand, research suggests the peptide may have anti-cancer properties, including the ability to reset gene expression patterns toward healthier states
Verify current regulatory status with your prescriber and pharmacy before making medication decisions.
912 Most of these are not aggravated or caused by GLP-1 receptor agonists, except possibly gallbladder disease